The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment

Haznedaroglu I. C.

EXPERT OPINION ON PHARMACOTHERAPY, cilt.14, sa.11, ss.1431-1436, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 14 Sayı: 11
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1517/14656566.2013.799140
  • Dergi Adı: EXPERT OPINION ON PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1431-1436
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

Introduction: Therapeutic stratification after the accurate essential thrombocythemia (ET) diagnosis is made based on the medical history (age, previous thrombosis), clinical assessments (cardiovascular [CV] risk factors, comorbidities, systemic diseases), laboratory examinations (leukocytosis, extreme thrombocytosis, anemia) and if available further sophistical analyses (CD34 count, JAK2V617F homozygosity, and mutant allele burden).